| Home > In process > Choosing the optimal mouse model for the study of late-onset spinal muscular atrophy: Why the 4-copy SMN2 model offers ideal translational relevance. |
| Journal Article (Review Article) | DZNE-2026-00935 |
; ; ; ; ; ; ; ; ; ; ;
2026
Sage
London
This record in other databases:
Please use a persistent id in citations: doi:10.1177/22143602251405151
Abstract: Spinal muscular atrophy (SMA) comprises a spectrum of clinical severities, yet the pathomechanisms of late-onset forms (Type III) remain insufficiently understood. While severe early-onset SMA has been extensively investigated using existing models, their translational relevance to adult disease is limited. Here, we recommend the 4-copy SMN2 mouse (FVB.Cg-Smn1tm1Hung Tg(SMN2)2Hung/J) as the most appropriate model for late-onset SMA. This model exhibits delayed onset, progressive motor dysfunction, and extended survival, enabling the study of chronic neurodegenerative processes, including astrocyte-mediated motor neuron pathology. Its prolonged therapeutic window makes the model suitable for mechanistic and translational investigations of late-onset SMA.
Keyword(s): Animals (MeSH) ; Disease Models, Animal (MeSH) ; Muscular Atrophy, Spinal: physiopathology (MeSH) ; Muscular Atrophy, Spinal: genetics (MeSH) ; Muscular Atrophy, Spinal: pathology (MeSH) ; Survival of Motor Neuron 2 Protein: genetics (MeSH) ; Mice (MeSH) ; Mice, Transgenic (MeSH) ; Translational Research, Biomedical (MeSH) ; late-onset SMA ; mouse models of SMA ; new treatments in late-onset SMA ; sma type 3 ; translational research ; Survival of Motor Neuron 2 Protein ; SMN2 protein, mouse
|
The record appears in these collections: |